缺血性卒中二级预防的研究进展

被引:9
作者
张世洪
刘鸣
机构
[1] 华西医科大学附属第一医院神经内科
关键词
缺血性卒中; 二级预防; 危险因素;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
缺血性卒中的二级预防指对已有脑缺血症状如短暂性脑缺血发作或缺血性卒中发作史的病人给予干预措施 ,以降低卒中发作和复发的危险。除对发生缺血性卒中的危险因素特别是与卒中复发有关的危险因素进行识别和纠正外 ,外科手术、抗凝药、抗血小板药物已广泛用于卒中的预防。文章就缺血性卒中二级预防的研究进展作了综述
引用
收藏
页码:232 / 234
页数:3
相关论文
共 19 条
[1]  
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. The New England Journal of Medicine . 1991
[2]  
Cholesterol lowering with statin drugs, risk of stroke, and total mortality.An overview of randomized trials. Hebert PR,Gaziano JM,Chan KS,et al. The Journal of The American Medical Association . 1997
[3]  
Stroke recurrence within two years after ischemic infarction. Hier DB,Foulkes MA,Swiontoniowski M,et al. Stroke . 1991
[4]  
Collaborative overview of randomized trials of antiplatelet therapy: I.prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’Collaboration. British Medical Journal . 1994
[5]  
European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. Diener HC,Cunha L,Forbes C,et al. Journal of the Neurological Sciences . 1996
[6]  
Secondary prevention for stroke after CAPRIE and ESPS-2. Dyken ML. Cerebrovascular Diseases . 1998
[7]  
The ticlopidine aspirin stroke study group: a randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Hass WK,Easton JD,Adams HP Jr,et al. The New England Journal of Medicine . 1989
[8]  
The international stroke trial(IST): a randomized trial of aspirin, subcutaneous heparin both, or neither among 19, 435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. The Lancet . 1997
[9]  
Beneficial effect of carotid endarterectomy in patients with symptomatic moderate or severe stenosis.North American Symptomatic Carotid Endarterectomy Trial Collaborators. Barnett HJM,Taylor DW,Eliasziw M,et al. The New England Journal of Medicine . 1998
[10]  
Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. European Atrial Fibrillation Trial Study Group. The New England Journal of Medicine . 1995